POSTPARTUM ACTIVATION OF AUTOIMMUNITY - TRANSIENT INCREASE OF TOTAL IGG LEVELS IN NORMAL WOMEN AND IN WOMEN WITH AUTOIMMUNE-THYROIDITIS
- 1 October 1987
- journal article
- research article
- Vol. 70 (1) , 68-73
Abstract
The immunoregulatory mechanisms underlying the transient rebound of autoimmune disease activity in the postpartum period were studied by determining serum immunoglobulins, thyroid microsomal antibodies and some viral (cytomegalovirus, Epstein-Barr, varicellae-zoster and mumps) and bacterial (Yersinia enterocolitica and Salmonella) antibodies in women with autoimmune thyroiditis and in healthy postpartum women. A characteristic increase between 2 and 5 months postpartum followed by a decrease to 10-12 postpartum was observed not only for thyroid microsomal antibody titres in women with autoimmune thyroiditis but also for serum total IgG and IgG subclass levels (but not IgM, IgA or IgE) in both groups of women. This pattern of transient antibody increase was not detected against viral and bacterial antigens. The characteristic alterations of thyroid microsomal antibody titres in the postpartum period of women with autoimmune thyroiditis thus appear to occur as a consequence of an activation of immunoglobulin-producing B cell clones. This activation seem restricted to the IgG class and to certain B cell clones.This publication has 7 references indexed in Scilit:
- Differential regulation of activation, clonal expansion, and antibody secretion in human B cells.The Journal of Immunology, 1985
- Herpesvirus Infections of PregnancyNew England Journal of Medicine, 1985
- Progress in enzyme immunoassays: production of reagents, experimental design, and interpretation.1985
- Maternal Adjustments in the Immune System in Normal PregnancyClinical Obstetrics and Gynecology, 1983
- Frequency and specificity of varicella zoster virus IgM responseJournal of Virological Methods, 1982
- An interchangeable elisa for cytomegalovirus antigen and antibodyJournal of Virological Methods, 1981
- Herpesvirus hominis Infection in Patients with Myeloproliferative and Lymphoproliferative DisordersBMJ, 1972